Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FBXL6 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBXL6 mRNA | CTD | PMID:36331819 | FBXL6 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBXL6 mRNA | CTD | PMID:22206623 | FBXL6 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fbxl6 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXL6 mRNA | CTD | PMID:21570461 | FBXL6 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FBXL6 mRNA | CTD | PMID:32109520 and PMID:33387578 | FBXL6 | Human | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | FBXL6 | Human | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Fbxl6 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of FBXL6 mRNA | CTD | PMID:18648102 | FBXL6 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FBXL6 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FBXL6 mRNA | CTD | PMID:32699268 | FBXL6 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FBXL6 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FBXL6 mRNA | CTD | PMID:32699268 | FBXL6 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of FBXL6 mRNA | CTD | PMID:24449571 | FBXL6 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FBXL6 gene | CTD | PMID:25304211 | FBXL6 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FBXL6 gene | CTD | PMID:25304211 | FBXL6 | Human | bisphenol A | increases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of FBXL6 mRNA | CTD | PMID:25181051 | FBXL6 | Human | bisphenol A | increases expression | ISO | Fbxl6 (Mus musculus) | 6480464 | bisphenol A results in increased expression of FBXL6 mRNA | CTD | PMID:33221593 | FBXL6 | Human | cadmium atom | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXL6 mRNA | CTD | PMID:37325564 | FBXL6 | Human | cadmium dichloride | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXL6 mRNA | CTD | PMID:37325564 | FBXL6 | Human | chlorpyrifos | increases expression | ISO | Fbxl6 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of FBXL6 mRNA | CTD | PMID:37019170 | FBXL6 | Human | choline | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBXL6 gene | CTD | PMID:20938992 | FBXL6 | Human | Cuprizon | increases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of FBXL6 mRNA | CTD | PMID:26577399 | FBXL6 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FBXL6 mRNA | CTD | PMID:20106945 | FBXL6 | Human | dibutyl phthalate | decreases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of FBXL6 mRNA | CTD | PMID:21266533 | FBXL6 | Human | ethanol | affects expression | ISO | Fbxl6 (Mus musculus) | 6480464 | Ethanol affects the expression of FBXL6 mRNA | CTD | PMID:30319688 | FBXL6 | Human | fenvalerate | decreases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | fenvalerate results in decreased expression of FBXL6 mRNA | CTD | PMID:30307764 | FBXL6 | Human | folic acid | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | FBXL6 | Human | folic acid | decreases expression | ISO | Fbxl6 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of FBXL6 mRNA | CTD | PMID:25629700 | FBXL6 | Human | L-methionine | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBXL6 gene | CTD | PMID:20938992 | FBXL6 | Human | lead diacetate | decreases expression | ISO | Fbxl6 (Mus musculus) | 6480464 | lead acetate results in decreased expression of FBXL6 mRNA | CTD | PMID:21829687 | FBXL6 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FBXL6 mRNA more ... | CTD | PMID:32699268 | FBXL6 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fbxl6 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBXL6 mRNA | CTD | PMID:36331819 | FBXL6 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of FBXL6 mRNA | CTD | PMID:21632981 | FBXL6 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXL6 mRNA | CTD | PMID:23557933 | FBXL6 | Human | Soman | decreases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of FBXL6 mRNA | CTD | PMID:19281266 | FBXL6 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of FBXL6 mRNA | CTD | PMID:31533062 | FBXL6 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of FBXL6 mRNA | CTD | PMID:31758290 | FBXL6 | Human | thioacetamide | increases methylation | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased methylation of FBXL6 promoter | CTD | PMID:27914986 | FBXL6 | Human | titanium dioxide | decreases expression | ISO | Fbxl6 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FBXL6 mRNA | CTD | PMID:29264374 | FBXL6 | Human | trichloroethene | increases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of FBXL6 mRNA | CTD | PMID:33387578 | FBXL6 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of FBXL6 mRNA | CTD | PMID:28818685 | FBXL6 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of FBXL6 gene | CTD | PMID:29154799 | FBXL6 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of FBXL6 mRNA | CTD | PMID:29154799 | FBXL6 | Human | vinclozolin | decreases expression | ISO | Fbxl6 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of FBXL6 mRNA | CTD | PMID:23034163 | |